BOUDES P .Drug compliance in therapeutic trials:a review [ J]: Control Clin T rials,1998, 19(3):257-268.
Karlson CW, Rapoff MA. Attrition in randomized controlled trials for pediatric chronic conditions. J Pediatr Psychol. 2009;34(7):782–93.
McDonald AM, Knight RC, Campbell MK, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7(1):9.
Tooher RL, Middleton PF, Crowther CA. A thematic analysis of factors influencing recruitment to maternal and perinatal trials. BMC Pregnancy Childbirth. 2008;8(100967799):36.
Tudur Smith C, Hickey H, Clarke M, Blazeby J, Williamson P. The trials methodological research agenda: results from a priority setting exercise. Trials 2014;15:32.
MK Yu; Y Xu; RX Hu. Characteristics of the methodological studies on patient compliance in clinical trials in China. Chin J Evid-Based Med. 2019,19(06):708-714.
 Brintnall-Karabelas J, Sung S, Cadman ME, Squires C, Whorton K. Improving recruitment in clinical trials: why eligible participants decline. J Empir Res Hum Res Ethics. 2011;6(1):69
Driscoll K, Killian M, Johnson S, Silverstein J, Deeb L. Predictors of study completion and withdrawal in a randomized clinical trial of a pediatric diabetes adherence intervention. Contemp Clin Trials. 2009; 30(101242342):212-220.
Soumya J. Niranjan ,Raegan W. Durant,Jennifer A. Wenzel,etc.Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials[J].J Canc Educ,2019,34:26-34.
Eleanor Ladd Schneider Leavens , Elise Marie Stevens ,Emma Irene Brett,etc.Use of Rideshare Services to Increase Participant Recruitment and Retention in Research: Participant Perspectives[J].JOURNAL OF MEDICAL INTERNET RESEARCH,2019,21(4):e11166.
Laura A. Novak,Bradley E. Belsher,Michael C. Freed,Phoebe K. McCutchan,Xian Liu,Daniel P. Evatt,Terri Tanielian,Robert M. Bray,Charles C. Engel. Impact of financial reimbursement on retention rates in military clinical trial research: A natural experiment within a multi-site randomized effectiveness trial with active duty service members[J]. Contemporary Clinical Trials Communications,2019,15.
Zhou Q, Ratcliffe S J, Grady C, et al. Cancer Clinical Trial Patient-Participants’ Perceptions about Provider Communication and Dropout Intentions[J]. AJOB empirical bioethics, 2019, 10(3): 190-200.
Wisk LE, Nelson EB, Magane KM,etc.Clinical Trial Recruitment and Retention of College Students with Type 1 Diabetes via Social Media: An Implementation Case Study[J].Journal of Diabetes Science and Technology,2019,13(3):445-456. doi: 10.1177/1932296819839503.
JS Liang, KW Huang. Effects of drug clinical trial programs on subject compliance and management strategies [J]. China Health Industry, 2019, 16 (11): 89-91. DOI: 10.16659 / j.cnki.1672 -5654.2019.11.089.
Henshall C, Narendran P, Andrews R C, et al. Qualitative study of barriers to clinical trial retention in adults with recently diagnosed type 1 diabetes[J]. BMJ open, 2018, 8(7): e022353.
Schoor R, Bruce A, Bruce J, et al. Reasons for nonadherence and response to treatment in an adherence intervention trial for relapsing–remitting multiple sclerosis patients[J]. Journal of clinical psychology, 2019, 75(3): 380-391.
Grace Cannard K, Hacker M L, Molinari A, et al. Recruitment and Retention in Clinical Trials of Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Past Experiences and Future Considerations[J]. Journal of Parkinson's disease, 2018, 8(3): 421-428.
Grape A, Rhee H, Wicks M, et al. Recruitment and retention strategies for an urban adolescent study: lessons learned from a multi-center study of community-based asthma self-management intervention for adolescents[J]. Journal of adolescence, 2018, 65: 123-132.
Daykin A, Clement C, Gamble C, et al. ‘Recruitment, recruitment, recruitment’–the need for more focus on retention: a qualitative study of five trials[J]. Trials, 2018, 19(1): 76.
Arame Thiam-Diouf, Barbara Metch , Cameron Sharpe ,etc.Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention[J].Vaccine,2018,36(9):1235-1242.
YS Xu, S Wei, YC Zeng, et al. Investigation of factors influencing the compliance of subjects in drug clinical trials and nursing strategies [J]. Journal of Clinic Nursing's Practicality, 2018, 3 (33): 29- 30. DOI: 10.3969 / j.issn.2096-2479.2018.33.024.
Joshua Wynne,Rosemary Muwawu,Michael C Mubiru,Betty Kamira,Doreen Kemigisha,Teopista Nakyanzi,Samuel Kabwigu,Clemensia Nakabiito,Flavia Kiweewa Matovu. Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study[J]. HIV Clinical Trials,2018,19(5).
Minick S G , May S B , Rivet A K , et al. Participants' perspectives on improving retention in HIV care after hospitalization: A post-study qualitative investigation of the MAPPS study[J]. PLOS ONE, 2018, 13(8):e0202917.
Chhatre S , Jefferson A , Cook R , et al. Patient-centered recruitment and retention for a randomized controlled study[J]. Trials, 2018, 19(1):205.
Carter Rosalind J, Senesi Reynold G B, Dawson Peter,ETC. Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)[J]. Journal of Infectious Diseases, 2018(suppl_1):suppl_1.
Y Xiong. Experience of subject compliance management in phase I drug clinical trials [J] .Diet Health, 2018,5 (20): 46. DOI: c 10.3969 / j.issn.2095-8439.2018.20.055.
 Okhomina V I, Seals S R, Anugu P, et al. Adherence and retention of African Americans in a randomized controlled trial with a yoga-based intervention: the effects of health promoting programs on cardiovascular disease risk study[J]. Ethnicity & Health, 2018: 1-13.
Rios-Romenets S, Acosta-Baena N, Lopez L, et al. Adherence/Retention Alzheimer's Prevention Initiative Colombia Plan[J]. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2018, 4: 283-287.
Ulrich C M, Deshmukh S, Pugh S L, et al. Attrition in NRG Oncology's Radiation-Based Clinical Trials[J]. International Journal of Radiation Oncology* Biology* Physics, 2018, 102(1): 26-33.
JX Tao, XD Li , HL Liang, TQ He , M Ren , CX Lu , MQ Yu , DY Yan , YL Huangfu. Bushen Quxie Fang combined with entecavir in the treatment of chronic hepatitis B in a multi-center clinical study of subjects’clinical compliance and influencing factors[J].Journal of Traditional Chinese Medicine,2018,59(19):1661-1666.DOI:10.13288/j.11-2166/r.2018.19.011.
JH Liu. Study on the effect of nursing intervention on subject compliance in drug clinical trials [J]. Special Health, 2018 (16).
J Yang, XQ Liu, L Fan, et al. Analysis and counterpotential approaches of subject management in the phase I clinical trials of drugs [J]. Medical Diet and Health, 2018, (5): 187,190.
Joanna C Crocker,Ignacio Ricci-Cabello,Adwoa Parker,Jennifer A Hirst,Alan Chant,Sophie Petit-Zeman,David Evans,Sian Rees. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis[J]. BMJ,2018,363.
Boada M, Santos-Santos M A, Rodríguez-Gómez O, et al. Patient engagement: the fundacío ACE framework for improving recruitment and retention in Alzheimer’s disease research[J]. Journal of Alzheimer's Disease, 2018, 62(3): 1079-1090.
 HL Duan , ZJ Du , WR Zhang , XF Dong. Based on literature review of influencing factors of subject compliance[J].World Latest Medicine Information,2018,18(98):146-148.DOI:10.19613/j.cnki.1671-3141.2018.98.063.
Babatunde O A, Adams S A, Wirth M D, et al. Predictors of retention among African Americans in a randomized controlled trial to test the Healthy Eating and Active Living in the Spirit (HEALS) intervention[J]. Ethnicity & disease, 2017, 27(3): 265.
Julia Lawton , David White, David Rankin ,etc.Staff experiences of closing out a clinical trial involving withdrawal of treatment: qualitative study[J].Trials,2017,18:61.
J. Lloyd, C. McHugh, J. Minton,etc.The impact of active stakeholder involvement on recruitment, retention and engagement of schools, children and their families in the cluster randomised controlled trial of the Healthy Lifestyles Programme (HeLP): a school-based intervention to prevent obesity[J].Trials,2017,18(1):378.
David A. Rorie, Robert W. V. Flynn , Isla S. Mackenzie,etc.The Treatment In Morning versus Evening (TIME) study: analysis of recruitment, follow-up and retention rates post- recruitment[J].Trials,2017,18(1):557.
HM Wang,HJ Li. Analysis of full-course nursing intervention to improve the compliance of malignant tumor subjects in drug clinical trials [J]. Journal of Clinic Nursing's Practicality, 2017, 2 (44): 133,138. DOI: 10.3969 / j. issn.2096-2479.2017.44.111.
Pfammatter Angela Fidler,Mitsos Alexa,Wang Shirlene,Hood Susan Hammett,Spring Bonnie. Evaluating and improving recruitment and retention in an mHealth clinical trial: an example of iterating methods during a trial.[J]. mHealth,2017,3.
Kannisto Kati Anneli,Korhonen Joonas,Adams Clive E,Koivunen Marita Hannele,Vahlberg Tero,Välimäki Maritta Anneli. Factors Associated With Dropout During Recruitment and Follow-Up Periods of a mHealth-Based Randomized Controlled Trial for Mobile.Net to Encourage Treatment Adherence for People With Serious Mental Health Problems.[J]. Journal of medical Internet research,2017,19(2).
Kearney Anna,Daykin Anne,Shaw Alison R G,Lane Athene J,Blazeby Jane M,Clarke Mike,Williamson Paula,Gamble Carrol. Identifying research priorities for effective retention strategies in clinical trials.[J]. Trials,2017,18(1).
Paul A. Leighton,Stephen D. Brealey,Joseph J. Dias. Interventions to improve retention in a surgical, clinical trial: A pragmatic, stakeholder‐driven approach[J]. Journal of Evidence‐Based Medicine,2018,11(1).
Lawrie T A, Betrán A P, Singata-Madliki M, et al. Participant recruitment and retention in longitudinal preconception randomized trials: lessons learnt from the Calcium And Pre-eclampsia (CAP) trial[J]. Trials, 2017, 18(1): 500.
 Beishuizen C R L, Coley N, Moll van Charante E P, et al. Determinants of dropout and nonadherence in a dementia prevention randomized controlled trial: The prevention of dementia by intensive vascular care trial[J]. Journal of the American Geriatrics Society, 2017, 65(7): 1505-1513.
Comerford M, Lourens S, Liangpunsakul S, et al. Challenges in patient enrollment and retention in clinical studies for alcoholic hepatitis: Experience of the TREAT Consortium[J]. Alcoholism: Clinical and Experimental Research, 2017, 41(12): 2000-2006.
Ware, R.S., L. McPherson and N.G. Lennox, Drop-out during a randomized trial with adolescents with intellectual disability was associated with participant burden, while drop-out at study exit was associated with carer and household characteristics. Research in Developmental Disabilities, 2017. 71: 53-60.
ZC Cai . Factors influencing the compliance of subjects in clinical trials of antitumor drugs and pharmaceutical interventions[J].Chinese Community Doctors,2017,33(09):13+15.DOI:10.3969/j.issn.1007-614x.2017.9.6.
JJ Jin , GM Zhang , SS Song, et al. Discussion on the management of subjects in the clinical trial of phase Ⅰ drugs for blood diseases [J]. Journal of Nurses Training, 2017, 32 (15): 1378-1380. DOI: 10.16821 / j.cnki .hsjx.2017.15.011.
YW Zhang, Y Li. Analysis of the causes of subject dropout and clinical counterpotential approaches in clinical trials of drugs . For All Health, 2017,11(7):13.
Y Jin,QY Zhang,LR Li.Analysis and counterpotential approaches of the drop-out of subjects in clinical trials of breast cancer drugs[J].Chinese Clinical Oncology,2017,22(2):161-166. DOI:10.3969/j.issn.1009-0460.2017.02.013.
 Kadam R A, Borde S U, Madas S A, et al. Challenges in recruitment and retention of clinical trial subjects[J]. Perspectives in clinical research, 2016, 7(3): 137.
Ashley Salazar, Susan Tolivaisa, Donna Allard,etc.What We Have Learned About Best Practices for Recruitment and Retention in Multicenter Pregnancy Studies[J].Semin Perinatol,2016,40(5):321-327.
CJ Feng, L Yue,YR Jiang.Discussion on the causes and counterpotential approaches of subject dropout in clinical trials of endocrine professional drugs [J] .Medical Frontier, 2016,6 (9): 233-234.
Thayabaranathan T, Cadilhac DA, Srikanth VK,etc.Maximizing Patient Recruitment and Retention in a Secondary Stroke Prevention Clinical Trial: Lessons Learned from the STAND FIRM Study[J].J Stroke Cerebrovasc Dis,2016,25(6):1371-1380.
Atherton P J , Burger K N , Pederson L D , et al. Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992)[J]. Clinical Trials, 2016:1740774516655101.
HB Zhang. Nursing management of subject follow-up compliance in phase III drug clinical trials [J]. Nursing and Rehabilitation Journal, 2016, 15 (4): 375-377. DOI: 10.3969 / j.issn.1671- 9875.2016.04.022.
Miguel, A. Q. C., Madruga, C. S., Cogo-Moreira, H., Yamauchi, R., Simões, V., da Silva, C. J., McPherson, S., Roll, J. M., & Laranjeira, R. R. Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: A randomized controlled trial. Psychology of Addictive Behaviors, 2016, 30(5): 536–543. https://doi.org/10.1037/adb0000192
Comeli A. Reasons for subjects' unwillingness to comply in clinical trials of pre-exposure preventive medicine [J]. Chinese Journal of Preventive Medicine, 2016, 50 (9): 793-793.
HY Fan ,XJ Wang , S Jing , et al. Analysis of the causes of shedding of subjects in clinical trials of antihypertensive drugs and strategies[J].Chinese Journal of Medical Science Research Management,2016,29(3):173-175,184. DOI:10.3760/cma.j.issn.1006-1924.2016.03.004.
HY Li , FF Feng , ZW Tian, LL Wang . Factors influencing the compliance of subjects in clinical trials of antitumor drugs and pharmaceutical intervention[J].World Latest Medicine Information,2016,16(04):173-174.
H Zhang, J He, X Zhao, et al. Nursing intervention of the study nurse’s compliance with the subjects in the phase I clinical trial of drugs [J]. Military Medical Journal of Southeast China, 2016, 18 (1): 86-87, 108. DOI: 10.3969 / j.issn.1672-271X.2016.01.028.
GX Chen. On the management of subject compliance in clinical trials of new drugs [J]. Journal of Medicine & Pharmacy of Chinese Minorities, 2016,22 (3): 55-56. DOI: 10.3969 / j.issn.1006-6810.2016. 03.035.
Louise Robinson,Pauline Adair,Margaret Coffey,Rebecca Harris,Girvan Burnside. Identifying the participant characteristics that predict recruitment and retention of participants to randomised controlled trials involving children: a systematic review[J]. BioMed Central,2016,17(1).
Berge E , Stapf C , Al-Shahi Salman R ,etc.Methods to improve patient recruitment and retention in stroke trials[J].International Journal of Stroke,2016,11(6):663-676.
Shiovitz T M , Bain E E , Mccann D J , et al. Mitigating the Effects of Nonadherence in Clinical Trials[J]. Journal of Clinical Pharmacology, 2015, 56(9):1151-1164.
Moodie E E M, Karran J C, Shortreed S M. A case study of SMART attributes: a qualitative assessment of generalizability, retention rate, and trial quality[J]. Trials, 2016, 17(1): 242.
V C Brueton, J F Tierney, S Stenning,etc.Strategies to improve retention in randomised trials: a Cochrane systematic review and meta-analysis[J].BMJ Open,2014,2(4):e003821.
Johnson Natalie A,Kypri Kypros,Latter Joanna,McElduff Patrick,Attia John,Saitz Richard,Saunders John B,Wolfenden Luke,Dunlop Adrian,Doran Christopher,McCambridge Jim. Effect of telephone follow-up on retention and balance in an alcohol intervention trial.[J]. Preventive medicine reports,2015,2.
Boden-Albala, Bernadette,Carman, Heather,Southwick, Lauren, et al.Examining Barriers and Practices to Recruitment and Retention in Stroke Clinical Trials[J].Stroke: A Journal of Cerebral Circulation,2015,46(8):2232-2237.
Blaha Robert Z,Arnett Anne B,Kirkwood Michael W,Taylor H Gerry,Stancin Terry,Brown Tanya M,Wade Shari L. Factors influencing attrition in a multisite, randomized, clinical trial following traumatic brain injury in adolescence.[J]. The Journal of head trauma rehabilitation,2015,30(3).
Barbro L , Kristian L , Judith B , et al. Participant Experiences in the Environmental Determinants of Diabetes in the Young Study: Common Reasons for Withdrawing[J]. Journal of Diabetes Research, 2016, 2016:1-13.
ComeliA, Perry B, McKenna K, et al. Participants’ explanations for non-adherence in the FEM-PrEP clinical trial[J]. E PIDEMIOLOGY AND P REVENTION, 2015.
Langford D P, Fleig L, Brown K C, et al. Back to the future–feasibility of recruitment and retention to patient education and telephone follow-up after hip fracture: a pilot randomized controlled trial[J]. Patient preference and adherence, 2015, 9: 1343.
Olds, D.L., Baca, P., McClatchey, M. et al. Cluster Randomized Controlled Trial of Intervention to Increase Participant Retention and Completed Home Visits in the Nurse-Family Partnership. Prev Sci, 2015, 16:778-788. https://doi.org/10.1007/s11121-015-0563-x.
XX Wang. Analysis of the effect of compliance education on clinical trial subjects[C]. Chinese Journal of Hypertension.Chinese Journal of Hypertension:Chinese Journal of Hypertension,2015:534.
L Zhang, JM Guo, CQ Kang, et al. Analysis and counterpotential approaches of the subject management of drug clinical trials in our hospital [J]. China Medical Herald, 2015, 12 (6): 140-144.
M Yang. Analysis of the reasons for the drop-out of subjects in the Phase I clinical trial of drugs and counterpotential approaches [J]. Medicine and Health Care, 2015, (10): 209-210.
Tangrea, J. A . Patient Participation and Compliance in Cancer Chemoprevention Trials: Issues and Concerns[J]. Experimental Biology & Medicine, 1997, 216(2):260-265.
Mood L, Hassouneh D, McNeff E. A Conceptual Model to Promote the Retention of Women with Physical Disabilities in Research[J]. Public Health Nursing, 2015, 32(4): 368-377.
Wells A A, Palinkas L A, Williams S L L, et al. Retaining low-income minority cancer patients in a depression treatment intervention trial: Lessons learned[J]. Community mental health journal, 2015, 51(6): 715-722.
Carlson M, Jackson J, Mandel D, et al. Predictors of retention among African American and Hispanic older adult research participants in the well elderly 2 randomized controlled trial[J]. Journal of Applied Gerontology, 2014, 33(3): 357-382.
Marjorie C. McCullagh, Marie-Anne Sanon, Michael A. Cohen.Strategies to enhance participant recruitment and retention in research involving a community-based population[J].Applied Nursing Research,2014,27(4).
Mary Fischer, WHNP-BC, NCMP,etc.Use of pragmatic community-based interventions to enhance recruitment and adherence in a randomized trial of Tai Chi for women with osteopenia: insights from a qualitative substudy[J].Menopause,2014,21(11):1181-1189.
W Wang. The effect of psychological intervention on the compliance of the new drug phase III clinical trial subjects [J]. Today Nurse (Late Journal), 2014, (12): 109-110.
XW Qiao.Investigation and Analysis of the Causes of the Shedding of the Subjects with Inhalation of Phlegm Heat Clearing Atomization [J].Nei Mongol Journal of Traditional Chinese Medicine,2014,33(21):88-89. DOI:10.3969/j.issn.1006-0979.2014.21.096.
Busisiwe Magazi,Jonathan Stadler,Sinead Delany-Moretlwe,Elizabeth Montgomery,Florence Mathebula,Miriam Hartmann,Ariane van der Straten. Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa[J]. BioMed Central,2014,14(1).
Olubukola T Idoko,Olumuyiwa A Owolabi,Aderonke A Odutola,Olatunde Ogundare,Archibald Worwui,Yauba Saidu,Alison Smith-Sanneh,Abdoulie Tunkara,Gibbi Sey,Assan Sanyang,Philip Mendy,MartinO C Ota. Lessons in participant retention in the course of a randomized controlled clinical trial[J]. BioMed Central,2014,7(1).
Kim R , Hickman N , Gali K , et al. Maximizing Retention With High Risk Participants in a Clinical Trial[J]. American Journal of Health Promotion, 2014, 28(4):268-274.
LP Mai, YH Wu, XP Wang, et al. Discussion on the methods of subject management in Phase I clinical trials of drug [J]. The Journal of Evidence-Based Medicine, 2014, 14 (4): 240-243, 256. DOI: 10.3969 / j. issn.1671-5144.2014.04.015.
Q Zhang. How to improve the compliance of subjects in clinical trials of drugs [J]. Medical Information, 2014, (37): 389-389. DOI: 10.3969/j.issn.1006-1959.2014.37.603.
YG Li, Q Yang, JE Zeng, et al. Causes and counterpotential approaches of subject dropout in clinical trials of drugs [J]. Herald of Medicine, 2014, (7): 975-976. DOI: 10.3870 / yydb. 2014.07.042
P Huang,R Zuo ,CH Xia ,YQ Xiong . On the experience of subject management in Phase I clinical trials [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19 (03): 320-322.
YG Li, JE Zeng,Q Yang, et al. Talking about informed consent of drug clinical trials and subject compliance [J]. Medical Information, 2014, (3): 46-46. DOI: 10.3969 / j.issn .1006-1959.2014.03.057.
J Wei,HL Liu,LC Wang.Discussion on strategies to improve the compliance of subjects in clinical trials of acupuncture and moxibustion [J].Beijing Journal of Traditional Chinese Medicine,2014,33(2):97-99.
WK Zheng, B Chang, J Chen. Improving participant adherence in clinical research of traditional chinese medicine.[J]. Evidence-based complementary and alternative medicine : eCAM,2014:376058.
Lopes R T, Gonçalves M M, Sinai D, et al. Predictors of dropout in a controlled clinical trial of psychotherapy for moderate depression[J]. International Journal of Clinical and Health Psychology, 2015, 15(1): 76-80.
Knippschild S, Hirsch J, Krummenauer F. Metaanalysis to estimate the expected drop out-rates reported in clinical trials on cataract surgery[J]. 2014.
Plummer M L, Watson-Jones D, Lees S, et al. A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania[J]. AIDS care, 2010, 22(4): 499-508.
Warner E T, Glasgow R E, Emmons K M, et al. Recruitment and retention of participants in a pragmatic randomized intervention trial at three community health clinics: results and lessons learned[J]. BMC public health, 2013, 13(1): 192.
Murphy E J, Kassem L, Chemerinski A, et al. Retention and attrition among African Americans in the STAR* D study: what causes research volunteers to stay or stray?[J]. Depression and anxiety, 2013, 30(11): 1137-1144.
Margaret Pribulick , Ishan Canty Willams, Pamela Stewart Fahs,etc.STRATEGIES TO REDUCE BARRIERS TO RECRUITMENT AND PARTICIPATION[J].Online J Rural Nurs Health Care,2013,10(1):22-33.
V C Brueton, F Stevenson, C L Vale,etc.Use of strategies to improve retention in primary care randomised trials: a qualitative study with in-depth interviews[J].BMJ Open,2014,4:e003835.
 CC Xia, YJ Zhu. Influencing factors and pharmaceutical interventions of subjects ’compliance in clinical trials of stroke treatment drugs [J]. China Modern Medicine, 2013, 20 (31): 154-155.
Lewis AL, Baker N, Carpenter M,etc.Does physician continuity within a clinical trial increase retention and compliance among adolescent smokers?[J]. Adolesc Psychiatry (Hilversum),2013,3(2).
SY Liu , ZF Jiang , XY Yu . Nursing intervention of subject compliance in clinical trials of HER-2 positive early breast cancer drugs[J].Chinese Journal of Modern Nursing,2013,19(27):3323-3325. DOI:10.3760/cma.j.issn.1674-2907.2013.27.007.
SZ Hu. Compliance analysis and intervention potential approaches in clinical trials of asthma patients [J]. Health Required (Late Journal), 2013, (8): 459-460.
Atassi N, Yerramilli-Rao P, Szymonifka J, et al. Analysis of start-up, retention, and adherence in ALS clinical trials[J]. Neurology, 2013, 81(15): 1350-1355.
Koog Y H, Gil M, We S R, et al. Barriers to participant retention in knee osteoarthritis clinical trials: a systematic review[C]//Seminars in arthritis and rheumatism. WB Saunders, 2013, 42(4): 346-354.
Gatehouse C S, Tennen H A, Feinn R S, et al. Association between interactive voice response adherence and subject retention in a randomized controlled trial[J]. Contemporary clinical trials, 2012, 33(4): 589-592.
YY Kou , YQ Tang , JQ Wu , Y Zhang , M Li , JF Feng . Factors influencing the compliance of subjects in clinical trials of antitumor drugs and pharmaceutical interventions[J].China Pharmacy,2012,23(18):1711-1713.DOI:10.6039/j.issn.1001-0408.2012.18.32.
QW Rao. Management of subjects ’compliance with medication in clinical trials of drugs [J]. Chinese Journal of Aesthetic Medicine, 2012, 21 (14): 693-694. DOI: 10.3969 / j.issn. 14.534.
 YM Hu, JY Zhao, JH Jiang, et al. Analysis of the reasons for the shedding of subjects in clinical trials of a hospital and discussion on the counterpotential approaches [J]. Anhui Medical Journal, 2012, 33 (2): 214-216. DOI: 10.3969 / j. issn.1000-0399.2012.02.038.
Vellas B , Hampel H , Rouge-Bugat M E , et al. Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology[J]. journal of nutrition health & aging, 2012, 16(4):339-345.
 Hui D, Glitza I, Chisholm G, et al. Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials[J]. Cancer, 2013, 119(5): 1098-1105.
Y Zhang ,L Shi , WJ Jiang , XH Zeng . Influencing factors and counterpotential approaches of compliance in clinical trials[J].China Pharmaceuticals,2012,21(02):13-14. DOI:10.3969/j.issn.1006-4931.2012.02.008.
Collins B N, Wileyto E P, Hovell M F, et al. Proactive recruitment predicts participant retention to end of treatment in a secondhand smoke reduction trial with low-income maternal smokers[J]. Translational behavioral medicine, 2011, 1(3): 394-399.
Deborah A. Gust,Barudi Mosimaneotsile,Unami Mathebula, et al.Risk Factors for Non-Adherence and Loss to Follow-Up in a Three-Year Clinical Trial in Botswana[J].,2011.
Sue Penckofer,Mary Byrn,Patricia Mumby,Carol Estwing Ferrans. Improving Subject Recruitment, Retention, and Participation in Research through Peplau’s Theory of Interpersonal Relations[J]. Nursing Science Quarterly,2011,24(2).
Brubaker L , Richter H E , Barber M D , et al. Pelvic floor disorders clinical trials: participant recruitment and retention[J]. International Urogynecology Journal, 2013, 24(1):73-79.
BURGESS, L, J, et al. Patient retention gifts in clinical trials: undue inducement or justified motivational tools?.[J]. Samj South African Medical Journal, 2011.
Kalkhuis-Beam S, Stevens SL, Baumritter A,etc.Participant- and study-related characteristics predicting treatment completion and study retention in an adolescent smoking cessation trial.[J].Journal of Adolescent Health,2011,49(4):371-378.
XN Wang ,YQ Yuan , SH Fan, et al. Effect of nursing intervention on subject compliance in drug clinical trials[J].CHINESE JOURNAL OF MODERN NURSING,2011,17(19):2285-2287. DOI:10.3760/cma.j.issn.1674-2907.2011.19.019.
J Xiong, ZH Chi,RX Chen.Discussion on improving the compliance of multi-center moxibustion clinical trial subjects [J].China Journal of Traditional Chinese Medicine and Pharmacy,26(8):1780-1782.
Burgess L M, Sulzer N U. Retrospective analysis of a South African cardiovascular trial site’ s patient retention rates[J]. Open Access J Clin Trials, 2010, 2: 163-166.
Anne-Marie Shields, Mihyun Park, Sandra E. Ward,etc.Subject Recruitment and Retention Against Quadruple Challenges in an Intervention Trial of End-of-Life Communication[J].J Hosp Palliat Nurs,2010,12(5):312-318.
CM Zhai, LN Xia, DY Huang, et al. Observation of the effect of holistic nursing on subject compliance in clinical trials of new drugs [J]. China Foreign Medical Treatments, 2010, 29 (25): 161. DOI: 10.3969 / j.issn. 1674-0742.2010.25.129.
Grill J D, Karlawish J. Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials[J]. Alzheimer's research & therapy, 2010, 2(6): 34.
Magner R,Borg A,Rosal MC, et al.Translational research at community health centers: challenges and successes in recruiting and retaining low-income Latino patients with type 2 diabetes into a randomized clinical trial.[J].The Diabetes educator,2010,36(5):733-749.
Gul B R, Ali A P, et al, Clinical trials: the challenge of recruitment and retention of participants. Journal of Clinical Nursing, 2010, 19: 227-233. doi:10.1111/j.1365-2702.2009.03041.x
Lindström D, et al., Disappointment and drop-out rate after being allocated to control group in a smoking cessation trial. Contemporary Clinical Trials, 2010. 31(1): 22-26.
YJ Huang , SB Ding. Influencing factors and potential approaches of subject compliance in anti-tumor drug clinical trials[J].INTERNATIONAL JOURNAL OF NURSING,2010,29(2):308-309. DOI:10.3760/cma.j.issn.1673-4351.2010.02.072.
DC Fan. Methods of evaluating and improving subject compliance [J]. China Prescription Drug, 2010, (4): 70-71.
DC Fan.Analysis method of enrollment rate and subject's compliance [J].China Prescription Drug,2010,(3):70-71.
GD Lu, SH Xi, R Li, et al. Analysis and counterpotential approaches of subjects ’individual non-compliance factors in drug clinical trials [J]. Nursing Journal of Chinese People's Liberation Army, 2009, 26 (9): 30-31, 50. DOI: 10.3969 / j.issn.1008-9993.2009.09.010.
Haleh Sangi-Haghpeykar, Hannah M. Meddaugh, H Liu,etc.Attrition and retention in clinical trials by ethnic origin[J].Contemporary Clinical Trials,2009,30:499-503.
Merran Toerien, Sara T Brookes, Chris Metcalfe,etc.A review of reporting of participant recruitment and retention in RCTs in six major journals[J].Trials,2009,10:52.
HY Liu, JX Chen, L Xia, et al. Influencing factors and counterpotential approaches of subject compliance in clinical trials of traditional Chinese medicine new drugs [J]. Zhejiang Journal of Traditional Chinese Medicine, 2009, 44 (12): 923. DOI: 10.3969 / j. issn.0411-8421.2009.12.044.
LJ Tian,SX Wang,XJ Gao.Psychological investigation and intervention potential approaches of subjects before participating in clinical trials [J].Hebei Medical Journal,2009,31(13):1674-1675. DOI:10.3969/j.issn.1002-7386.2009.13.082.
SX Wang, SJ Zhang.Analysis of the reasons why the subjects completed the clinical trial [J].
Nursing Practice and Research,2009,6(19):124-125. DOI:10.3969/j.issn.1672-9676.2009.19.072.
Guzmn Anglica,Richardson Irma M,Gesell Sabina,Barkin Shari L. Recruitment and Retention of Latino Children in a Lifestyle Intervention[J]. American journal of health behavior,2009,33(5).
Claire S Leathem,Margaret E Cupples,Mary C Byrne,Mary O'Malley,Ailish Houlihan,Andrew W Murphy,Susan M Smith. Identifying strategies to maximise recruitment and retention of practices and patients in a multicentre randomised controlled trial of an intervention to optimise secondary prevention for coronary heart disease in primary care[J]. BioMed Central,2009,9(1).
 Chang MW, Brown R, Nitzke S.Participant recruitment and retention in a pilot program to prevent weight gain in low-income overweight and obese mothers[J].BMC Public Health,2009,9:24. https://doi.org/10.1186/1471-2458-9-424
Cox LE.Predictors of medication adherence in an AIDS clinical trial: patient and clinician perceptions[J].Health Soc Work,2009,34(4):257-264.https://doi.org/10.1093/hsw/34.4.257.
X Zhang, Y Zhang, YH Zhao. Reflections on compliance issues in clinical trials of new drugs [J]. MEDICINE AND PHILOSOPHY, 2009, 30 (24): 69-70.
XX Wang,YM Li,J Gao.Study on the subject's compliance in clinical trials of drugs [J].Chinese Remedies & Clinics,2009,9(6):507-508. DOI:10.3969/j.issn.1671-2560.2009.06.019.
YP Bao , Z Liu, Epstein D H, et al. A meta-analysis of retention in methadone maintenance by dose and dosing strategy[J]. The American journal of drug and alcohol abuse, 2009, 35(1): 28-33.
SM Xue . Causes and management of shedding cases in clinical trials of new orthopedic drugs[J].Chinese Journal of Current Hospital Adminestration,2009,007(012).
Sharika Gappoo, Elizabeth T. Montgomery, Caitlin Gerdts, et al. Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe[J]. Contemporary Clinical Trials, 2009, 30(5):411-418.
Higginson Irene, Hart Sam,Burman Rachel,Silber Eli,Saleem Tariq,Edmonds Polly. Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up[J]. BMC Palliative Care,2008,7(1).
Siddiqi A A, Sikorskii A, Given C W, et al. Early participant attrition from clinical trials: role of trial design and logistics[J]. Clinical Trials, 2008, 5(4): 328-335.
GD Lu ,LL Zhang, QY Xiu , et al. Analysis and treatment of the subject ‘s shedding in clinical trials of drugs [J]. Nursing Journal of Chinese People's Liberation Armyl, 2008, 25 (20): 17-19. DOI: 10.3969 /j.issn.1008-9993.2008.20.007.
GD Lu ,LL Zhang. Subject compliance management in clinical trials of drugs [J]. Hospital Administration Journal of Chinese People's Liberation Army, 2008, 15 (3): 293-295. DOI: 10.3969 / j.issn. 9985.2008.03.048.
S. S. Bull,D. Vallejos,D. Levine,C. Ortiz. Improving recruitment and retention for an online randomized controlled trial: experience from the Youthnet study[J]. AIDS Care,2008,20(8).
Victoria Villacorta , Susan Kegeles, Jerome Galea,etc.Innovative approaches to cohort retention in a community-based HIV/STI prevention trial for socially marginalized Peruvian young adults[J].Clinical Trials,2007,4:32-41.
Glasgow Russell E,Nelson Candace C,Kearney Kathleen A,Reid Robert,Ritzwoller Debra P,Strecher Victor J,Couper Mick P,Green Beverly,Wildenhaus Kevin. Reach, engagement, and retention in an Internet-based weight loss program in a multi-site randomized controlled trial.[J]. Journal of medical Internet research,2007,9(2).
J Xiao, F Tan, B Chen. Subject compliance issues in clinical trials of new drugs [J]. Chinese Journal of New Drugs, 2007, 16 (6): 420-423. DOI: 10.3321 / j.issn: 1003-3734.2007.06.002.
Maurice Andrew,Howell Anthony,Evans D Gareth,O'Neil Alison C,Scobie Sue. Predicting compliance in a breast cancer prevention trial.[J]. The breast journal,2006,12(5).
Mor M, Niv G, Niv Y.Patient Retention in a Clinical Trial: A Lesson from the Rofecoxib (VIOXX) Study[J].Digestive Diseases and Sciences,2006,51(7):1175-1178.
Dias L, Schoenfeld E, Thomas J, et al. Reasons for high retention in pediatric clinical trials: comparison of participant and staff responses in the Correction of Myopia Evaluation Trial[J]. Clinical Trials, 2005, 2(5): 443-452.
Wiemann C M , Chacko M R , Tucker J C , et al. Enhancing Recruitment and Retention of Minority Young Women in Community-Based Clinical Research[J]. J Pediatr Adolesc Gynecol, 2005, 18(6):403-407.
Avins A L, Bent S, Neuhaus J M. Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study[J]. Contemporary clinical trials, 2005, 26(3): 397-401.
Steven K, Dobscha, Kathryn Corson, Jeffrey Solodky, and Martha S. Gerrity. Use of Vission Research:Enrollment, Retention, and Patient Satisfaction.Telemedicine and e-Health.2005, 11: 84-89.http://doi.org/10.1089/tmj.2005.11.84
J Zhang, GX Lin, XW Zhang. Talking about the compliance of subjects and researchers in clinical trials of new drugs [J].Liaoning Journal of Traditional Chinese Medicine, 2005, 32 (8): 854-855. DOI: 10.3969 / j. issn.1000-1719.2005.08.083.
Raymond E G, Chen P L, Pierre-Louis B, et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness[J]. BMC medical research methodology, 2004, 4(1): 23.
Mazzuca S A , Brandt K D , Katz B P , et al. Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug[J]. Arthritis & Rheumatism, 2004, 51(6):933-940.
de Bruyn, et al, Participant Retention in Clinical Trials of Candidate HIV Vaccines. JAIDS Journal of Acquired Immune Deficiency Syndromes, 2005. 39(4).
Sears S R, Stanton A L, Kwan L, et al. Recruitment and retention challenges in breast cancer survivorship research: results from a multisite, randomized intervention trial in women with early stage breast cancer[J]. Cancer Epidemiology and Prevention Biomarkers, 2003, 12(10): 1087-1090.
Bender B G, Ellison M C, Gleason M, et al. Minimizing attrition in a long-term clinical trial of pediatric asthma[J]. Annals of Allergy, Asthma & Immunology, 2003, 91(2): 168-176.
Adubato S, Alper R, Heenehan M, et al. Successful ways to increase retention in a longitudinal study of lead-exposed children[J]. Health & social work, 2003, 28(4): 312-315.
J Zeng ,GM Chen , RL Li . Subject compliance issues in clinical trials of new drugs[J].Chinese Journal of New Drugs and Clinical Remedies,2003(09):568-570. DOI:10.3969/j.issn.1007-7669.2003.09.016.
Sonawalla Shamsah B,Farabaugh Amy H,Leslie Vinita M,Pava Joel A,Matthews John D,Fava Maurizio. Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial[J]. Progress in neuro-psychopharmacology & biological psychiatry,2002,26(7-8):1415-1419.
Bulpitt Christopher J,Beckett Nigel S,Fletcher Astrid E,Thijs Lutgarde,Staessen Jan A,Dumitrascu Dan L,Forette Francoise,Leonetti Gastone,Nachev Choudomir,Tuomilehto Jaakko,Fagard Robert H. Withdrawal from treatment in the Syst-Eur Trial.[J]. Journal of hypertension,2002,20(2).
David C Mohr, Donald E Goodkin , Lorianne Masuoka,etc.Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis[J].Multiple Sclerosis,1999,5:192-197.
G Jónasson, K H Carlsen, A Sdal, et al. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma[J]. European Respiratory Journal, 1999, 14(1):150-154.
 Jordhøy M S, Kaasa S, Fayers P, et al. Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial[J]. Palliative medicine, 1999, 13(4): 299-310.
Grilo C M, Money R, Barlow D H, et al. Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder[J]. Comprehensive Psychiatry, 1998, 39(6): 323-332.
Bender B G, Iklé D N, DuHamel T, et al. Retention of asthmatic patients in a longitudinal clinical trial[J]. Journal of Allergy and Clinical Immunology, 1997, 99(2): 197-203.
Peter M. Milgrom, Philippe P. Hujoel, Philip Weinstein,etc.Subject Recruitment, Retention, and Compliance in Clinical Trials in Periodontics[J].Annals of Periodontology,1997,2(1):64-74.
Marion Good,Linda Schuler.Subject retention in a controlled clinical trial[J].Journal of Advanced Nursing,1996,26(2):351-355.
Blumenthal D S, Sung J, Coates R, et al. Mounting research addressing issues of race/ethnicity in health care: recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community[J]. Health Serv Res, 1995, 30: 197-205.
Epstein E E, McCrady B S, Miller K J, et al. Attrition from conjoint alcoholism treatment: Do dropouts differ from completers?[J]. Journal of substance abuse, 1994, 6(3): 249-265.
 Boyd N F, Cousins M, Kriukov V. A randomized controlled trial of dietary fat reduction: the retention of subjects and characteristics of drop outs[J]. Journal of clinical epidemiology, 1992, 45(1): 31-38.
 Alter M, Lai S M, Tournier B, et al. Acute stroke trials: Reasons for patient withdrawal[J]. Journal of Stroke and Cerebrovascular Diseases, 1991, 1(4): 182-189.
Morse EV, Simon PM, Coburn M,etc.Determinants of subject compliance within an experimental anti-HIV drug protocol[J].Social Science & Medicine,1991,32(10):1161-1167. DOI: 10.1016/0277-9536(91)90093-R
Kvien TK, Reimers S. Drug handling and patient compliance in an outpatient paediatric trial.J Clin Hosp Pharm. 1983 , 8(3):251-7.DOI:10.1111/j.1365-2710.1983.tb01104.x
Goldman A I, Holcomb R, Perry Jr H M, et al. Can dropout and other noncompliance be minimized in a clinical trial? Report from the Veterans Administrative National Heart, Lung and Blood Institute cooperative study on antihypertensive therapy: mild hypertension[J]. Controlled Clinical Trials, 1982, 3(2): 75-89.
 Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implemen Sci 2010;5:69. https://doi.org/10.1186/1748-5908-5-69.
Coombs LA, Hunt L, Cataldo J. A scoping review of the nurse practitioner workforce in oncology[J]. Cancer Med, 2016, 5(8):1908-1916．